Dynavax Technologies | Pasivo Circulante



Current Liabilities Cambio Fecha
AbbVie USD 36.4B 2.35B 2025-03
Adma Biologics USD 55.54M 10.65M 2024-12
Amgen USD 20.48B 2.53B 2025-06
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Dynavax Technologies USD 118.23M 49.85M 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
Glaxosmithkline GBP 21.7B 238M 2024-12
Merck USD 26.04B 863M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 31.71B 95M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Regeneron Pharmaceuticals USD 3.67B 100.4M 2025-06
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
TG Therapeutics USD 171.89M 11.68M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


Dynavax Technologies Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.